The primary market issue from Gland Pharma Limited was subscribed 2.06 times with the support of QIB’s. The non-institutional portion remained undersubscribed. The company had tapped the capital markets with its fresh issue of Rs 1,250 crs and an offer for sale of 3,48,63,635 equity shares in a price band of Rs 1,490-1500. Earlier the […]
Archive for the ‘General’ Category
Gland Pharma Limited – Subscribed just over 2 times
November 12th, 2020
Comments Off on Gland Pharma Limited – Subscribed just over 2 times
Market in Diwali Mood – New Lifetime Highs on the Anvil
November 9th, 2020
Comments Off on Market in Diwali Mood – New Lifetime Highs on the Anvil
Markets were on fire last week and had a great show, celebrating the upcoming Diwali festival in advance. BSESENSEX was up 2,278.99 points or 5.75% to close at 41,893.06 points while NIFTY gained 621.15 points or 5.34% to close at 12,263.55 points. The broader market saw BSE100, BSE200 and BSE500 gain 5.14%, 4.97% and 4.68% […]
Gland Pharma Limited – Completes Anchor Allocation
November 9th, 2020
Comments Off on Gland Pharma Limited – Completes Anchor Allocation
Gland Pharma Limited which is tapping the capital markets with its simultaneous fresh issue and offer for sale completed allocation to anchor investors. The company allotted 1,29,59,089 shares to 70 anchor investors comprising of 131 entities. The highest allocation was made to Smallcap World Fund who was allotted 8,57,400 shares or 6.62% of the anchor […]
